Cycurion Inc (CYCU) Stock Analysis
Verdict: AVOID
Severe cash burn ($12.5M/yr) and working capital deficit leave Cycurion reliant on share dilution despite recent $800k contract wins.
Investment score: 28/100
Analysis as of
Is Cycurion Inc stock worth reviewing? The TradeMates thesis
The TradeMates model assigns an AVOID recommendation due to acute balance sheet distress, negative operating cash flows of -$12.1M, and imminent capital raising requirements.
7-factor investment score
- Valuation: 25/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 30/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Cycurion Inc opportunities and risks
What speaks for CYCU
- Expansion of municipal cybersecurity contracts ($800K NACCHO award)
What speaks against CYCU
- Imminent cash runway exhaustion and share dilution
Peers and competitors
- RGP
- AUC
- WFCF
- IGPK
- PCMC
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CYCU | n/a | 0.3x | n/a | 17.2% | -98.0% | -261.0% |
| RGP | n/a | 0.3x | n/a | 37.5% | -9.0% | 0.2% |
| AUC | n/a | 12.3x | n/a | 100.0% | -513.7% | -1.6% |
| WFCF | 49.3x | 2.8x | 23.6x | 38.3% | 5.8% | 1.4% |
| IGPK | 16.2x | 0.3x | 54.2x | 2.4% | 0.4% | 3.3% |
| PCMC | n/a | 0.0x | n/a | 0.0% | 0.0% | -1.9% |
| Peer median | n/a | 0.3x | n/a | 37.5% | 0.0% | 0.2% |
Frequently asked questions about Cycurion Inc (CYCU)
Is CYCU stock a good investment?
The TradeMates model rates Cycurion Inc as AVOID with an investment score of 28/100. The TradeMates model assigns an AVOID recommendation due to acute balance sheet distress, negative operating cash flows of -$12.1M, and imminent capital raising requirements. This is algorithmic model output, not personal investment advice.
Is CYCU stock a buy?
The TradeMates model verdict for CYCU is AVOID with an investment score of 28/100. Treat this as a model signal to review, not a personal buy recommendation.